C07D 233/50
With carbocyclic radicals directly attached to said nitrogen atoms
Official title: with carbocyclic radicals directly attached to said nitrogen atoms
C07D233/50 (With carbocyclic radicals directly attached to said nitrogen atoms) appears on 144 US grants and 75 published applications in this corpus.
Search patents in C07D- Granted patents
- 144
- Published applications
- 75
- Assignees
- 78
- Inventors
- 307
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 11 | 0 |
| 1982 | 5 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 6 | 0 |
| 1986 | 5 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 6 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 6 | 0 |
| 2001 | 5 | 0 |
| 2002 | 2 | 5 |
| 2003 | 3 | 11 |
| 2004 | 9 | 7 |
| 2005 | 2 | 5 |
| 2006 | 5 | 3 |
| 2007 | 4 | 2 |
| 2008 | 1 | 8 |
| 2009 | 0 | 1 |
| 2010 | 2 | 5 |
| 2011 | 1 | 2 |
| 2012 | 1 | 1 |
| 2013 | 3 | 2 |
| 2014 | 3 | 3 |
| 2015 | 4 | 1 |
| 2016 | 1 | 6 |
| 2017 | 3 | 2 |
| 2018 | 1 | 4 |
| 2019 | 4 | 1 |
| 2020 | 0 | 2 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Epoxide functionalized polyaromatic feedstock and polymers derived therefrom10 Mar 2026US 12,570,623 B2ExxonMobil Technology and Engineering Company
- Therapeutic compounds11 Jun 2024US 12,006,294 B2Regents of the University of Minnesota
- Pharmaceutical salts/co-crystals of pentoxifylline, clonidine and linsidomine with caffeic, protocatechuic or alpha-lipoic acid an use thereof for treatment of pain29 Nov 2022US 11,510,926 B2The Royal Institution for the Advancement of Learning/Mcgill University
- Hydrogen sulfide donor in organic salt form and preparation method therefor21 Sep 2021US 11,124,475 B2Chengdu Kaoensi Science and Technology Co., Ltd.
- Electronic device and compound3 Sep 2019US 10,403,824 B2Novaled GmbH
- Novel carboxy ligands and use thereof in catalysts18 Dec 2025US 2025/0381554 A1BASF SE
- Methods of treating alpha adrenergic mediated conditions2 Mar 2023US 2023/0062049 A1Allergan, Inc.
- Epoxide functionalized polyaromatic feedstock and polymers derived therefrom15 Sep 2022US 2022/0289700 A1ExxonMobil Technology and Engineering Company
- Pharmaceutical salts/co-crystals of pentoxifylline, clonidine and linsidomine with caffeic, protocatechuic or alpha-lipoic acid an use thereof for treatment of pain15 Jul 2021US 2021/0213025 A1The Royal Institution for the Advancement of Learning/Mcgill University
- Methods of treating alpha adrenergic mediated conditions22 Oct 2020US 2020/0330428 A1Allergan, Inc.
Most cited
By later US patents
- Meta-substituted phenylene derivatives72US 5,773,646 AG. D. Searle & Co. · 1998
- Method for treating hypertension with disubstituted granidine compounds45US 5,385,946 AState of Oregon, acting by and through the Oregon State Board of Higher Education, acting for and on behalf of the Oregon Health Sciences University and the University of Oregon · 1995
- Substituted guanidines having high binding to the sigma receptor and the use thereof41US 5,312,840 AState of Oregon, acting by and through the Oregon State Board of Higher Education · 1994
- CETP inhibitors38US 7,652,049 B2Merck & Co., Inc. · 2010
- Method of lowering intraocular pressure using phenylimino-imidazoles33US 4,515,800 A1985